ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Aimmune Therapeutics, Inc.
31 Août 2020 - 6:01PM
Business Wire
Rowley Law PLLC is investigating potential securities law
violations by Aimmune Therapeutics, Inc. (NASDAQ: AIMT) and its
board of directors concerning the proposed acquisition of the
company by Nestlé S.A. Stockholders will receive $34.50 in cash for
each share of Aimmune Therapeutics stock that they hold. The
transaction is valued at approximately $2.6 billion and is expected
to close in the fourth quarter of 2020.
If you are a stockholder of Aimmune Therapeutics, Inc. and are
interested in obtaining additional information regarding this
investigation, please visit us at:
http://www.rowleylawpllc.com/investigation/aimt/. You may
also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street
Suite 1000, White Plains, NY 10606, by email at
info@rowleylawpllc.com, or by telephone at 914-400-1920 or
844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class
actions and derivative lawsuits in complex corporate litigation.
For more information about the firm and its attorneys, please visit
http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200831005562/en/
Shane Rowley, Esq. Rowley Law PLLC info@rowleylawpllc.com
914-400-1920 or 844-400-4643 (toll-free)
Aimmune Therapeutics (NASDAQ:AIMT)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Aimmune Therapeutics (NASDAQ:AIMT)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Aimmune Therapeutics Inc (NASDAQ): 0 recent articles
Plus d'articles sur Aimmune Therapeutics, Inc.